CRVS SG&A Expense Growth
Corvus Pharmaceuticals Inc · SG&A Expense Growth
CRVS SG&A Expense Growth
Latest reported13.34%period ending
CRVS FY SG&A Growth (YoY) (0.00% → 13.34%)
Latest values, visible window
High-resolution chart · PNG
CRVS sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 13.3407% | |
| 18.631% | |
| -15.0179% | |
| -14.9028% | |
| -20.2431% | |
| 9.6608% | |
| 2.2847% | |
| 4.0806% | |
| 34.1076% | |
| 215.1365% | |
| 1,702.0301% | |
| 0% |